Bolte Axel

Chief Executive Officer at Inozyme Pharma, Inc.; Director at IVERIC bio, Inc.

Sold, on record
$29k
Dollars the filings state
Form 4 sales
2
Latest Jun 24, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale IVERIC bio, Inc.Unusual
    Dec 30, 2016 2016

    Sold 6,000 shares at $4.83 ($29k)

    Bolte Axel, Director

    Sold 100% of holdings ($29k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Inozyme Pharma, Inc.Unusual
    Jun 24, 2021 +1637 days

    Sold 66,788 shares

    Bolte Axel, Chief Executive Officer

    Sold 25.9% of holdings190,825 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Bolte Axel
Source
Jun 24, 2021Jun 25, 2021Inozyme Pharma, Inc.Chief Executive OfficerForm 4 sale66,78825.9%UnusualSEC
Dec 30, 2016Jan 23, 2017IVERIC bio, Inc.DirectorForm 4 sale6,000$29k100.0%UnusualSEC